Cassava Sciences | PTIE - La Marge Brute Sur Les Ventes





La Marge Brute Sur Les Ventes Changement Date
Abbott USD 6.54B 625M 2025-12
Amgen USD 6.48B 307M 2025-09
Biogen USD 1.65B 34.6M 2025-12
Cara Therapeutics USD 2.57M 1.11M 2025-03
Cassava Sciences USD -3.96M 1.16M 2025-09
Eisai JPY 168.85B 17.02B 2025-12
Eli Lilly USD 14.59B 1.48B 2025-09
Geron USD 46.71M 525K 2025-12
J&J USD 16.6B 118M 2025-12
Merck USD 13.42B 431M 2025-09
Novartis USD 10.25B 570M 2025-12
Novavax USD 125.04M 76.09M 2025-12
Pfizer USD 3.54B 7.61B 2025-09
Roche Holding CHF 22.09B 10.04B 2025-12